What is Kolanticon Gel
1. Name Of The Medicinal Product
2. Qualitative and quantitative composition
Kolanticon Gel is a white viscous suspension containing 2.5mg dicycloverine hydrochloride, 200mg aluminum hydroxide, 100mg light magnesium oxide, 20mg simethicone per 5ml.
3. Pharmaceutical form
Suspension for oral administration.
4. Clinical Particulars
4.1 Therapeutic Indications
Treatment and prophylaxis of symptoms of peptic ulcer and functional dyspepsia especially in patients in whom gastric distress results from hyperacidity, smooth muscle spasm, including irritable bowel syndrome (IBS), and flatulence. Also indicated for symptomatic relief in oesophagitis, hiatus hernia, gastritis and iatrogenic gastritis.
4.2 Posology And Method Of Administration
Two to four 5ml spoonfuls every four hours as required.
Known idiosyncrasy to any of the ingredients. Should not be used in patients with prostatic enlargement, glaucoma, obstructive uropathy, obstructive disease of the gastro-intestinal tract, paralytic ileus and intestinal atony, severe ulcerative colitis, and myasthenia gravis.
4.4 Special Warnings And Precautions For Use
In the presence of renal insufficiency magnesium salts may cause central nervous system depression. Aluminum hydroxide in the presence of low phosphorous diets may cause phosphorous deficiency. Aluminum hydroxide may reduce absorption of tetrayclines when given concomitantly. Use with care in patients with hiatus hernia associated with reflux oesophagitis because anticholinergic drugs may aggravate this condition.
4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction
Antacids may interfere with the absorption of tetracyclines, ACE inhibitors, digoxin, rifampicin, ketoconazole, penicillamine, ciprofloxacin (and other quinolones), anticoagulants and biphosphonates, if given concurrently. Because of the large number of possible interactions they should not be given at the same time as any other drugs.
4.6 Pregnancy And Lactation
Epidemiological studies in pregnant women with products containing dicycloverine hydrochloride (at doses up to 40mg / day) have not shown that dicycloverine increases the risk of fetal abnormalities if administered during the first trimester of pregnancy. Reproduction studies have been performed in rats and rabbits at doses of up to 100 times the maximum recommended dose (based on 60mg per day for an adult person) and have revealed no evidence of impaired fertility or harm to the fetus due to dicycloverine.
For aluminum hydroxide, magnesium oxide and simethicone no clinical data on exposed pregnancies are available.
Caution should be exercised when prescribing to pregnant women.
Since the risk of teratogenicity cannot be excluded with absolute certainty for any product, the drug should be used during pregnancy only if clearly needed.
It is not known whether dicycloverine is secreted into human milk. Because many drugs are excreted in human milk, caution should be exercised when dicycloverine is administered to a nursing woman.
4.7 Effects On Ability To Drive And Use Machines
4.8 Undesirable Effects
In particularly sensitive patients dicycloverine hydrochloride may cause atropine-like
side effects such as dry mouth, blurred vision, urinary retention or constipation.
Signs and symptoms of dicycloverine hydrochloride overdose include: headache, nausea and vomiting, blurred vision, dilated pupils, hot dry skin, dizziness, vertigo, dryness of mouth, difficulty in swallowing and CNS stimulation.
5. Pharmacological Properties
5.1 Pharmacodynamic Properties
5.2 Pharmacokinetic Properties
Dicycloverine hydrochloride when given orally was rapidly and completely absorbed and the drug and / or its metabolites were found in the urine (dominant route of elimination) within 1 hour after drug ingestion. Plasma half-life of 4-6 hours was found for dicycloverine and / or its metabolites.
Act by local action in the stomach by neutralizing stomach acid and are largely unabsorbed.
5.3 Preclinical Safety Data
6. Pharmaceutical Particulars
6.1 List Of Excipients
Kolanticon Gel contains magnesium sulphate, methylcellulose 450, benzyl alcohol, sodium lauryl sulphate, saccharin sodium, alcohol 95%, methylparaben, propylparaben, butylparaben., Citric acid, oil of cinnamon, oil of peppermint, oil of spearmint, oil of cedar leaf, oil of nutmeg, menthol and eucalyptol.
6.3 Shelf Life
6.4 Special Precautions For Storage
Store below 25 ° C
6.5 Nature And Contents Of Container
Amber glass bottles of 200 and 500ml
6.6 Special Precautions For Disposal And Other Handling
Shake well before use.
7. Marketing Authorization Holder
Peckforton Pharmaceuticals Ltd,
8. Marketing Authorization Number (S)
9. Date Of First Authorization / Renewal Of The Authorization
15 October 1999
10. Date Of Revision Of The Text
- Ydp s31 specifications howard
- How to draw names out of a hat
- When it rains gasoline monologue Alysa Stanton
- Kwee seng ong wholesale
- 1 kg of rice serves how many people
- Lotro, where to find trolls in Angmar
- How to prevent goalkeeper gloves from smelling
- How to remove shiny eyes in pictures
- How to beat robot boss in Darksiders
- Veins or arteries collapse when they are empty
- Use of openacs tr-069 parameters
- What are keyboard scan codes
- Dholewala Chowk Ludhiana Punjab
- How To Get Plant Fiber Starbound Free
- How To Fix Dish Too Salty
- 27,000 million is like many billions
- What does SF mean in staple size
- Umbrella turned how to fix
- Selfie Stick, How To Use iPhone Camera
- Top master ad 630 khow
- Progresif Cellular, how to refill
- How do non-epileptic seizures feel?
- Assassin's Creed Rogue how to board ships
- Dancing red devil fireworks wholesale
- What is anteroseptal ischemia
- Debi Blackey Moonlight Company Howell
- When is the local loop open?
- Telugu actress Tara Chowdary taking pictures of Christmas
- Which model is Oldsmobile 49-3507
- Rexton trax 42 accessories wholesale
- What have we done, hobbit feet
- How to store your luxurious cosmetic products
- Who makes gekko bicycles
- How is the group-internal coordination carried out in SAP